Aclarion (ACONW) Stock Analysis

What Aclarion does

Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.

Key metrics

ETFs linked to ACONW

Broad-market and Healthcare sector ETFs an investor holding Aclarion is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ACONW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Aclarion?

Aclarion trades under the ticker ACONW on NASDAQ.

Which exchange is ACONW listed on?

ACONW is listed on NASDAQ.

What sector does Aclarion operate in?

Aclarion is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze ACONW in a portfolio?

PortView shows ACONW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.